Ardent Health's Divestment of St. Francis Campus Shows Asset's ROI Below Expectations, UBS Says

MT newswire2026/10/01 15:40

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

11:40 AM EDT, 10/01/2026 (MT Newswires) -- Ardent Health Partners' (ARDT) divestment of the St. Francis Campus to The University of Kansas Health System shows that the company believes its resources are better off deployed in opportunities with a higher return on investment, UBS said in a Wednesday note. The move seems to be part of the company's broader strategy to evaluate if its assets align with its long-term plans, UBS analysts said. Even though Ardent has improved the hospital's financial performance over the past decade, asset is generating returns "meaningfully" below the company's overall corporate average, according to the note. Ardent said that this particular market poses structural challenges to improving margins, including "unfavorable payor dynamics and sub-optimal competitive positioning," the analysts noted. After the transaction closes by year-end, Ardent noted that its EBITDA margin will increase by around 40 basis points, and it will look for opportunities to use the capital to boost long-term shareholder value, the analysts said. UBS has a buy rating on the stock, with a price target of $13.50. Price: 10.22, Change: -0.12, Percent Change: -1.16

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Indian Finance Minister Nirmala Sitharaman stated on Monday that the negotiation process has been "tough and stringent", and both parties have now reached a "plateau", making it "extremely difficult" for either side to make further concessions or requests. However, she left room for flexibility, saying: "If there is still room for maneuver, both parties will pursue it." Last Friday, US Trade Representative Jamieson Greer said that the negotiations were in their "final stages", but emphasized that a final agreement was not "imminent".

华尔街见闻•2026/10/05 19:41

Raia Drogasil controlador stake slips R$ 11.23 million after September cash share sales

Raia Drogasil internal dealing filings for 09/2026 showed spot share sales by the majority shareholder, totaling 624,000 shares for R$ 12.63 million. Weighted average sale price for the majority shareholder’s spot trades was R$ 20.2389 per share. Executives also reported spot share sales of 50,000 shares for R$ 1,016,435 at a weighted average price of R$ 20.3287. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Raia Drogasil SA published the original content used to generate this news brief on October 05, 2026, and is solely responsible for the information contained therein.

Bitget•2026/10/05 19:40

United States: Domestic rare earth production push – ING

FXStreet•2026/10/05 18:21